Launch of new subsection “Biological and biosimilar medicinal products” within the Medicinal products section
Within the "Medicinal products” Section on the webpages of the Agency for Medicinal Products and Medical Devices (HALMED) a new subsection "Biological and biosimilar medicinal products” has been launched.
HALMED is providing questions and answers related to properties of biological and biosimilar medicines, their quality, safety and efficacy requirements, marketing authorisation procedure and special requirements for post-authorisation monitoring of these medicines. Also, answers are given with regard to the interchangeability of biological and biosimilar medicinal medicinal products during treatment.
The subsection is accessible under this link.